Current Problems in Cancer
Volume 29, Issue 6 , Pages 285-295 , November 2005

Combining Information Across Symptom Studies

  • Pamela Atherton, MS
    • ,
  • Paul Novotny, MS

      Affiliations

    • Corresponding Author InformationAddress correspondence to Dr. Jeff A. Sloan, Mayo Clinic, Section of Biostatistics, Department of Health Science Research, 200 First St. S.W., Rochester, MN 55905, USA

References 

  1. Sloan JA . Quality-of-life meta-analysis (why treat it differently?) . J Clin Oncol . 2003;21(7):1422
  2. Cochrane Breast Cancer Group . Cochrane Database Syst Rev . 2004;4
  3. Farquhar C , Basser R , Marjoribanks J , Lethaby A . High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer . Cochrane Database Syst Rev . 2003;1:CD003142
  4. Moher D , Cook DJ , Jadad AR , Tugwell P , Moher M , Jones A , et al.   Assessing the quality of reports of randomised trials (implications for the conduct of meta-analyses) . Health Technol Assess . 1999;3(12):i–iv 1-98
  5. Loprinzi CL , Kugler JW , Sloan JA , Mailliard JA , Krook JE , Wilwerding MB , et al.   Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia . J Clin Oncol . 1999;17(10):3299–3306
  6. Jatoi A , Windschitl HE , Loprinzi CL , Sloan JA , Dakhil SR , Maillard JA , et al.   Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia . J Clin Oncol . 2002;20(2):567–573
  7. Sloan JA , Loprinzi CL , Novotny PJ , Okuno SL , Nair S , Barton DL . Sex differences in fluorouracil-induced stomatitis . J Clin Oncol . 2000;18(2):412–420
  8. Sloan JA , Goldberg R , Sargent DJ , Vargas-Chanes D , Nair S , Cha SS , et al.   Women experience greater toxicity with 5FU-based chemotherapy for colorectal cancer . J Clin Oncol . 2002;20(6):1491–1498
  9. Goldberg RM , Loprinzi CL , O’Fallon J , Veeder MH , Miser AW , Mailliard JA , et al.   Transdermal clonidine for ameliorating tamoxifen-induced hot flashes . J Clin Oncol . 1994;12:155–158
  10. Barton DL , Loprinzi CL , Quella SK , Sloan JA , Veeder MH , Egner J , et al.   Prospective evaluation of vitamin E for hot flashes in breast cancer survivors . J Clin Oncol . 1998;16(2):495–500
  11. Barton D , Loprinzi CL , Quella S , Sloan JA , Pruthi S , Novotny PJ . Depomedroxyprogestrerone acetate for hot flashes . J Pain Symptom Manage . 2002;24(6):603–607
  12. Loprinzi CL , Michalak JC , Quella SK , O’Fallon JR , Hatfield AK , Nelimark RA , et al.   Megestrol acetate for the prevention of hot flashes . N Engl J Med . 1994;331:347–352
  13. Loprinzi CL , Pisansky TM , Fonseca R , Sloan JA , Zahasky KM , Quella SK , et al.   Pilot evaluation of venlaflaxine hydrochloride for the therapy of hot flashes in cancer survivors . J Clin Oncol . 1998;16(7):2377–2381
  14. Loprinzi CL , Kugler JW , Sloan JA , Mailliard JA , LaVasseur BI , Barton DL , et al.   Venlafaxine in management of hot flashes in survivors of breast cancer (a randomised controlled trial) . Lancet . 2000;356:2059–2063
  15. Loprinzi CL , Barton DL , Sloan JA , Zahasky KM , Smith D , Pruthi S , et al.   Pilot evaluation of gabapentin for treating hot flashes . Mayo Clin Proc . 2002;77:1159–1163
  16. Loprinzi CL , Sloan JA , Perez EA , Quella SK , Stella PJ , Mailliard JA , et al.   Phase III evaluation of fluoxetine for treatment of hot flashes . J Clin Oncol . 2002;20(6):1578–1583
  17. Perez DG , Loprinzi CL , Barton DL , Pockaj BA , Sloan J , Novotny PJ , et al.   Pilot evaluation of mirtazapine for the treatment of hot flashes . J Support Oncol . 2004;2(1):50–56
  18. Quella S , Loprinzi C , Barton D , Knost J , Sloan J , LaVasseur B , et al.   Evaluation of soy phytoestrogens for treatment of hot flashes in breast cancer survivors (a North Central Cancer Treatment Group trial) . J Clin Oncol . 2000;18(5):1068–1074
  19. Sloan JA , Loprinzi CL , Novotny PJ , Barton DL , Lavasseur BI , Windschitl H . Methodologic lessons learned from hot flash studies . J Clin Oncol . 2001;19(19):4280–4290
  20. Martenson JA , Bollinger JW , Sloan JA , Novotny PJ , Urias RE , Michalak JC , et al.   Phase III double-blind placebo-controlled trial to assess the effectiveness of sucralfate in the prevention of treatment induced diarrhea in patients receiving pelvic radiation therapy . J Clin Oncol . 2000;18(6):1239–1245
  21. Kozelsky TF , Meyers GE , Sloan JA , Shanahan TG , Dick SJ , Moore RL , et al.   Phase III double-blind study of glutamine versus placebo for the prevention of acute diarrhea in patients receiving pelvic radiation therapy . J Clin Oncol . 2003;21(9):1669–1674

PII: S0147-0272(05)00057-7

doi: 10.1016/j.currproblcancer.2005.09.003

Current Problems in Cancer
Volume 29, Issue 6 , Pages 285-295 , November 2005

Article Tools

* Image Usage & Resolution